<DOC>
	<DOCNO>NCT02586805</DOCNO>
	<brief_summary>This phase 3 , multicenter , randomize , double-blind , placebo-controlled trial evaluate efficacy safety DX-2930 prevent acute angioedema attack patient Type I Type II HAE .</brief_summary>
	<brief_title>Efficacy Safety Study DX-2930 Prevent Acute Angioedema Attacks Patients With Type I Type II HAE</brief_title>
	<detailed_description />
	<mesh_term>Angioedema</mesh_term>
	<mesh_term>Angioedemas , Hereditary</mesh_term>
	<criteria>Males females 12 year age old time screen Documented diagnosis HAE , Type I II Baseline rate least 1 Investigatorconfirmed HAE attack per 4 week Adult subject caregiver subject age 18 willing able read , understand , sign inform consent form . Subjects age 12 17 , whose caregiver provide informed consent , willing able read , understand dsign assent form . Males femailes fertile sexually active must adhere contraception requirement . Concomitant diagnosis another form chronic , recurrent angioedema , acquire angioedema , idiopathic angioedema , recurrent angioedema associate urticaria . Participation prior DX2930 study Treatment investigational drug exposure investigational device within 4 week prior screen Exposure angiotensinconverting enzyme ( ACE ) inhibitor estrogencontaining medication within 4 week prior screen . Exposure androgens within 2 week prior enter runin period . Use longterm prophylactic therapy HAE within 2 week prior enter runin period . Use shortterm prophylaxis HAE within 7 day prior enter runin period . Any following liver function test abnormality : alanine aminotransferase ( ALT ) &gt; 3x upper limit normal , aspartate aminotransferase ( AST ) &gt; 3x upper limit normal , total bilirubin &gt; 2x upper limit normal ( unless bilirubin elevation result Gilbert 's syndrome ) . Pregnancy breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>DX-2930</keyword>
	<keyword>Hereditary Angioedema</keyword>
	<keyword>Dyax</keyword>
</DOC>